secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001641172-25-009744
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion delisted from Nasdaq; pivots to diagnostics via New Day license
----------------------------------------------------------------------

- Received Nasdaq delisting notice for failing to maintain $1.00 bid price and being deemed a public shell; trading suspended May 13, 2025.
- Expects common stock to trade on OTC Markets under symbol HEPA after suspension.
- Entered license agreement with New Day Diagnostics on May 9, 2025, for diagnostic tests (celiac, respiratory multiplex, H. pylori, HCC).
- Celiac, respiratory, and H. pylori tests have CE marks and are eligible for sale in Europe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000164117225009744/0001641172-25-009744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000164117225009744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer